Lobbying activity

Q4

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Animals, Budget/Appropriations

View → Q4

CHRONIC CARE POLICY ALLIANCE for CHRONIC CARE POLICY ALLIANCE

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate

Health Issues

View → Q4

JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC

4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate

Health Issues, Budget/Appropriations, Copyright/Patent/Trademark, Law Enforcement/Crime/Criminal Justice

View → Q4

ALSTON & BIRD LLP for TRAVERE THERAPEUTICS

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $80,000.00 income

Taxation/Internal Revenue Code, Medicare/Medicaid, Pharmacy, Health Issues

View → Q4

SPLITOAK STRATEGIES LLC for ALNYLAM PHARMACEUTICALS, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $60,000.00 income

Medicare/Medicaid

View → Q4

BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Homeland Security

View → Q4

THE NICKLES GROUP, LLC for MERCK & CO. INC.

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign)

View → Q4

NOVARTIS for NOVARTIS

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Medicare/Medicaid, Copyright/Patent/Trademark, Health Issues

View → Q4

DAIICHI SANKYO, INC. for DAIICHI SANKYO INC

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Health Issues, Taxation/Internal Revenue Code

View → Q4

FEROX STRATEGIES for ALEXION PHARMACEUTICALS, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $60,000.00 income

Health Issues

View → Q4

NEUROCRINE BIOSCIENCES, INC for NEUROCRINE BIOSCIENCES, INC

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate

Medicare/Medicaid, Health Issues, Budget/Appropriations, Taxation/Internal Revenue Code

View → Q4

AMGEN, INC. for AMGEN INC

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code, Copyright/Patent/Trademark

View → Q4

TAKEDA PHARMACEUTICALS AMERICA, INC. for TAKEDA PHARMACEUTICALS AMERICA INC

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q4

INCYTE CORPORATION for INCYTE CORPORATION

4th Quarter (Oct 1 - Dec 31) 2025 · Delaware · House · Senate

Medicare/Medicaid

View → Q4

TIBER CREEK GROUP for INCYTE CORPORATION

4th Quarter (Oct 1 - Dec 31) 2025 · Delaware · House · Senate · $80,000.00 income

Medicare/Medicaid

View → Q4

TIBER CREEK GROUP for EMD SERONO, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $50,000.00 income

Medicare/Medicaid, Health Issues

View → Q4

LUNDBECK LLC for LUNDBECK LLC

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Trade (domestic/foreign)

View → Q4

TIBER CREEK GROUP for ASTRAZENECA

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $90,000.00 income

Health Issues, Medicare/Medicaid

View → Q4

ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP

4th Quarter (Oct 1 - Dec 31) 2025 · Delaware · House · Senate

Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code

View → Q4

TIBER CREEK GROUP for ALNYLAM PHARMACEUTICALS, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $60,000.00 income

Medicare/Medicaid

View → Q4

PTC THERAPEUTICS, INC. for PTC THERAPEUTICS, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate

Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q4

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q4

W STRATEGIES, LLC for INCYTE CORPORATION

4th Quarter (Oct 1 - Dec 31) 2025 · Delaware · House · $60,000.00 income

Health Issues, Medicare/Medicaid

View → Q4

W STRATEGIES, LLC for CALIFORNIA LIFE SCIENCES

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · $40,000.00 income

Medicare/Medicaid

View → Q4

W STRATEGIES, LLC for ASTRAZENECA PHARMACEUTICALS LP

4th Quarter (Oct 1 - Dec 31) 2025 · Delaware · House · Senate · $80,000.00 income

Medicare/Medicaid

View →